CRP and COVID-19: Considering the hyperinflammatory nature of COVID-19 complications and the fact that mCRP dissociates from pCRP in proinflammatory microenvironments and it is also the main active proinflammatory isoform of CRP, we hypothesized that mCRP could be considered as a more specific prognostic marker of inflammatory progression and severity than pCRP in COVID-19.